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Abstract Expression of human endogenous retrovirus K
(HERV-K) is associated with germ-cell neoplasia. HERV-K
encodes a protein of the Rev/Rex family, cORF, that supports
cellular transformation and binds the promyelocytic leukemia
zinc finger (PLZF) protein implicated in spermatogenesis. Rev/
Rex function invariably depends on multimerization. Here we
show that cORF likewise self-associates to form higher-order
oligomers. Amino acids (aa) 47^87 in cORF are sufficient, aa
75^87 essential for self-association. Consistently, this domain is
predicted to form a hydrophobic K-helix that may represent an
oligomerization interface. The existence of a dimerization-
competent cORF mutant lacking PLZF-binding activity
(cORF47^87) suggests a way of dominant negative inhibition
of the proposed tumor susceptibility factor cORF. ß 2001 Fed-
eration of European Biochemical Societies. Published by Elsev-
ier Science B.V. All rights reserved.
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1. Introduction
Human endogenous retroviruses (HERVs) are the results of
germ-line infections of our simian and human ancestors by
exogenous retroviruses. Retroviral elements account for
V0.6^1% of the human genome. The only HERV family
known to still express all essential retroviral proteins leading
to release of the most probably uninfectious human teratocar-
cinoma-derived virus-like particles from de¢ned tissues is the
family HERV-K, represented by the most intact member
HERV-K (HML-2.HOM) located on chromosome 7 [1,2]. Be-
sides the basic proteins required for formation of retroviral
virions (e.g. a functional protease [3,4]) HERV-K expresses an
accessory 14.7 kDa gene product termed cORF. This protein
is of particular interest as it is ^ without showing any appar-
ent sequence homology at the amino acid level ^ a functional
homolog of the Rev protein encoded by the human immuno-
de¢ciency virus (HIV) and the Rex protein of the human T-
cell leukemia virus (HTLV). Like Rev and Rex, cORF is a
mainly nucleolar protein at steady state and performs nucleo-
cytoplasmic shuttling via the Crm1 pathway to mediate nu-
clear export of unspliced viral RNA species required for the
synthesis of structural proteins and enzymes [5,8].
HIV and HTLV are pathogens that can still not be con-
trolled. HIV causes a severe and incurable immunode¢ciency
[9]. HTLV-1 is the causative agent of the aggressive malig-
nancy adult T-cell leukemia and is associated with a chronic
neurodegenerative disorder termed tropical spastic paraparesis
[10]. Rev/Rex activity is essential for HIV/HTLV replication
and thus for viral pathogenicity. In the absence of Rev/Rex,
viral transcripts are retained in the nucleus and are subjected
to the cellular splicing machinery. Because of the lack of full-
length RNAs in the cytoplasm no infectious virus can be
produced [11].
HERVs have also been discussed to bear a pathogenic po-
tential, e.g. they have been linked to human autoimmune dis-
eases [12]. Furthermore, HERV-K expression is associated
with the occurrence of germ-cell tumors (GCTs) in that a
signi¢cant percentage of patients su¡ering from GCTs gener-
ate HERV-K Gag- and Env-reactive antibodies. Abundant
Gag expression is observed exclusively in the GCT cells but
not in the surrounding tissue [13]. The presence of HERV-K
cORF in GCTs is suggested by the observations that (i) cORF
activity seems to be a prerequisite for the e⁄cient expression
of HERV-K structural proteins and (ii) cORF protein is ex-
pressed in GCT-derived cell lines [5,6]. Hence, the active im-
plication of HERV-K in tumorigenesis cannot be ruled out. In
fact, we could recently demonstrate that the cORF protein
encoded by HERV-K induces tumors in nude mice. Further-
more, cORF interacts with the promyelocytic leukemia zinc
¢nger (PLZF) protein implicated in limb morphogenesis, cel-
lular di¡erentiation and spermatogenesis [14^17]. To further
analyze the e¡ect of cORF on cellular metabolism, a biochem-
ical characterization of the protein and its functions is indis-
pensable.
Rev and Rex have di¡erent functional domains. A nuclear
localization signal (NLS) mediates nuclear import by binding
to importin L [18,19]. The RNA-binding domain (RNAbd)
interacts with a highly conserved RNA secondary structure
within all incompletely spliced HIV or HTLV RNA species
(termed Rev or Rex response element, RRE or RxRE, respec-
tively). Furthermore, Rev and Rex use leucine-rich nuclear
export signals (NES) for direct binding to the Crm1 export
receptor and subsequent nuclear export of Rev/Rex and their
associated substrates. A further aspect of Rev/Rex function is
the potential to form oligomers. Multimer formation seems to
be necessary at the import step as well as in the process of
interaction with the RRE and the export machinery [20^22].
Like Rev and Rex, cORF possesses a NLS and a NES, and
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binds directly to Crm-1 [7,8,23]. Its function as a RNA export
protein requires the presence of a RNAbd, which has, how-
ever, not been mapped yet [6]. Hints towards a possible di-
merization came from mammalian two-hybrid experiments
[7]. As multimerization seems to be fundamental for the bio-
logical activity of Rev-like proteins, we further investigated
this feature of cORF.
2. Materials and methods
2.1. Plasmids
Plasmids pEG-cORF, pJG-cORF, pCep4-cORF and pGEX-cORF
contain the full-length cORF gene in a pEG202, pJG4-5 (kind gifts of
R. Brent, Boston, MA, USA, distributed by Clontech), pCep4 (Invi-
trogen) or pGEX-4T-1 (Pharmacia Biotech) backbone, respectively.
pJG-cORF deletion mutants comprise the amino acids in cORF given
with the name. All plasmids have been previously described [14]. The
pCep4-cORFre vector contains the cORF gene in reverse orientation
and was used as a negative control.
2.2. Cell culture, transfection and antibodies
Raji cells were cultured in RPMI 1640 plus 10% fetal calf serum
and were transfected with pCEP4-cORF or pCep4-cORFre vectors by
electroporation [14]. Transfected cells were selected by 0.3 mg hy-
gromycin B/ml to generate stable cell lines (Raji-cORF and Raji-
cORFre). Polyclonal rabbit antisera and monoclonal rat antibodies
were as previously described [14].
2.3. Yeast two-hybrid system
To test for protein interactions in yeast two-hybrid assays, yeast
strain EGY48 (carrying the lacZ reporter plasmid pSH18-34) was co-
transfected with pEG-202 and pJG4-5 derivatives using the lithium
acetate/polyethylene glycol method (according to the manufacturer’s
protocol, Matchmaker LexA, Clontech). Yeast clones were classi¢ed
positive if reporter genes (lacZ, LEU2) were activated only in the
presence of galactose but not in the presence of glucose, which inhibits
expression from the plasmid pJG4-5 (internal negative control). The
yeast strain EGY48 as well as reporter and control plasmids were
generous gifts of Roger Brent.
2.4. GST pulldown assays and Western blot analysis
Glutathione S-transferase (GST) or GST^cORF fusion protein was
generated by transforming Escherichia coli with plasmid pGEX-4T-1
or pGEX-4T-1-cORF, respectively. Exponentially growing cultures
were induced with isopropyl-1-thio-L-D-galactopyranoside for 4 h at
37‡C and cell pellets of 50 ml bacterial culture were resuspended in
5 ml GST lysis bu¡er (20 mM Tris^HCl pH 7.5, 200 mM NaCl, 1 mM
EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl £uoride)
and stored at 320‡C. Thawed suspension was sonicated for 1 min,
cleared supernatant was added to glutathione-Sepharose beads (1/20
volume) and incubated for 1 h at 4‡C with gentle shaking. Beads were
collected by centrifugation and washed three times in GST lysis bu¡-
er. 35 Wl of protein-coated beads (GST or GST^cORF) were incu-
bated with 220 Wl of native lysate (cells washed in phosphate-bu¡ered
saline (PBS) were lysed for 30 min on ice in lysis bu¡er (100 mM Tris^
HCl pH 8.0, 100 mM NaCl, 5 mM KCl, 0.5 mM MgCl2, 1 mM
CaCl2, 0.5% Nonidet P40, 1 mM dithiothreitol, 10 Wg/ml aprotinin)
and cellular debris was removed by centrifugation) from 2.2U1036
Raji or Raji-cORF cells for 1 h on ice. Pellets were washed six times
with GST lysis bu¡er and boiled for 5 min in SDS gel loading bu¡er
(125 mM Tris^HCl pH 6.8, 6.3% (w/v) SDS, 10% (v/v) 2-mercapto-
1,2-propanediol, 10% (v/v) glycerol) for release of bound protein. The
supernatant was loaded onto a 15% SDS^polyacrylamide gel and
blotted onto nitrocellulose membrane to test for cORF protein co-
precipitation (following standard protocols). Blots were blocked in 5%
non-fat dried milk in PBS pH 7.4 for 30 min and incubated overnight
at 4‡C with primary antibodies (polyclonal K-cORF antiserum, di-
luted 1:100 in 5% milk^PBS or monoclonal antibody in a dilution
of 1:15). After three washes for 20 min each in PBS, blots were
incubated with the secondary antibody (peroxidase-conjugated goat
anti-rabbit or goat anti-rat antibody, Sigma) in a dilution of 1:500 in
5% milk^PBS for 1 h at 4‡C. Blots were subjected to enhanced chem-
iluminescence immunodetection (Amersham) after further washing ac-
cording to the manufacturer’s protocol.
2.5. Glutaraldehyde crosslinking assay
Native extracts from 6U1035 Raji-cORF or Raji-cORFre cells (25
Wl) were mixed and incubated with 5 Wl of glutaraldehyde (GA) solu-
tions (diluted in water to give ¢nal concentrations as indicated) or
water as a control (3). After 15 min incubation at room temperature
the samples were tested for crosslinking of cORF oligomers in a West-
ern blot analysis using a cORF-speci¢c monoclonal antibody.
3. Results and discussion
3.1. HERV-K cORF dimerizes in vivo and in vitro
In a ¢rst approach to test for the self-association of cORF
we used the yeast two-hybrid system. Co-transfection of the
pEG-cORF vector encoding a fusion protein of cORF and the
Fig. 1. In vivo and in vitro self-association of cORF. A^C: L-Ga-
lactosidase reporter activity (blue) on medium containing X-Gal (X-
Gal, left side) and leucine-independent (Leu3, right side) growth of
colonies co-transfected to express interacting proteins in the yeast
two-hybrid system. Speci¢c interaction is only expected on galactose
medium (Gal) as glucose (Glu) represses expression from the vector
pJG4-5. Glucose-containing medium was therefore used as an inter-
nal negative control. The pictures show drop spots of two independ-
ent, representative yeast clones, grown on the indicated medium
composition; activation (+) or failing activation (3) of the respec-
tive reporter gene is shown in each panel. Yeast cells were co-trans-
fected with pEG-cORF plus pJG-cORF (A), pEG-cORF plus pJG4-
5 (B) or pEG202 plus pJG-cORF (C). D: Immobilized GST (lanes
1+3) or GST^cORF fusion protein (lanes 2+4) was incubated with
native extracts from Raji cells expressing (lanes 3+4) or not express-
ing (lanes 1+2) cORF. cORF binding was investigated in a Western
blot of Sepharose-bound protein using polyclonal cORF-speci¢c
rabbit antiserum. Extract from Raji-cORF cells was used as a posi-
tive control in lane 5, positions of the cORF protein and the GST^
cORF fusion protein as well as of marker proteins are indicated;
cORF-reactive bands in lanes 2 and 4 are degradation products of
GST^cORF.
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LexA DNA-binding domain and of pJG4-5-cORF, encoding
a fusion of cORF and the transactivation domain of the Gal4
transcription factor, led to speci¢c activation of a LexA-de-
pendent reporter system in yeast. Activation of the reporter
genes is due to interaction of the two cORF hybrid proteins
reconstituting a functional LexA transactivator and is visual-
ized by blue staining of the colonies on medium containing X-
Gal and growth of the colonies on medium lacking leucine. In
contrast, no activation was observed in control transfections
(i.e. in combination with the respective parental vectors, Fig.
1B,C).
To con¢rm the homo-multimerization of cORF we per-
formed GST pulldown assays. GST or GST^cORF fusion
protein was coupled to glutathione-Sepharose beads and in-
cubated with native lysate of Raji cells stably transfected to
produce cORF (Raji-cORF) or of control cells (Raji-
cORFre). Matrix-associated protein was subjected to Western
blot analysis using a cORF-speci¢c polyclonal rabbit antise-
rum. As can be seen in Fig. 1D, only Sepharose beads loaded
with GST^cORF fusion protein precipitated cORF protein
from Raji-cORF cell extract while Sepharose beads loaded
with the GST moiety alone did not (compare lanes 3, 4 and
positive control in lane 5), demonstrating that cORF speci¢-
cally self-associates in this assay. No signi¢cant amount of
cORF protein was precipitated by either Sepharose beads
loaded with GST^cORF or GST from Raji cORFre cell ex-
tract lacking cORF protein (lanes 1 and 2). Since we never
detected the expression of cORF in Raji cells that were not
stably transfected with a cORF expression vector beforehand,
the very faint cORF signal in lane 2 most likely results from
cleavage of an ^ obviously very small ^ part of the GST^
cORF protein (thrombin cleavage site between GST and the
fusion moiety resulting from usage of vector pGEX-4T-1)
resulting in the release of cORF protein that can subsequently
bind to GST^cORF. The higher-molecular cORF-reactive
species in lanes 2 and 4 represent GST^cORF and degrada-
tion products of the latter. In conclusion, these experiments
clearly show that cORF self-associates in vivo and in vitro.
3.2. cORF forms di-, tri-, and tetramers
To analyze the oligomerization order, i.e. the number of
Fig. 2. cORF multimers are stabilized after GA crosslinking. Before (lanes 1+8) and after (lanes 2^7 and 9) incubation of native extracts of
cORF expressing (lanes 1^7) or not expressing (lanes 8+9) Raji cells in increasing concentrations of GA (as indicated), cORF-speci¢c signals
were detected in a Western blot analysis with a cORF-speci¢c monoclonal antibody. The positions and molecular masses of marker proteins
and the cORF-speci¢c protein species are indicated.
Fig. 3. Mapping of interaction sites using the yeast two-hybrid sys-
tem. Shortened fragments of cORF covering the indicated amino
acids (given with the names) were tested for interaction with the
full-length cORF protein. Results of speci¢c activation of the yeast
two-hybrid reporter system (+) are shown on the right. Functional
domains are indicated above: the NLS as de¢ned by Magin et al.
[23] and the NES de¢ned by Boese et al. [8]. The black bar repre-
sents the domain identi¢ed to be essential for dimerization. Addi-
tionally, K-helices (K1 and K2) in the predicted secondary structure
are indicated with hydrophobic amino acids as plain letters, hydro-
philic amino acids as letters in open circles.
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cORF monomers that associate, we performed GA crosslink-
ing experiments. GA is a reagent that connects proteins situ-
ated in close proximity, which is only given if proteins are
interacting. We therefore incubated native extracts from
cORF expressing cells with GA solution appropriately diluted
to give ¢nal concentrations of 0.001, 0.005, 0.01, 0.03, 0.07
and 0.1% GA. Samples were then tested for crosslinking of
cORF oligomers in a Western blot analysis using a cORF-
speci¢c monoclonal antibody. As can be seen in Fig. 2, at GA
concentrations higher than 0.001% additional bands appear
besides the cORF monomer band at 14.7 kDa with molecular
weights of about 28, 41, and 53 kDa. At a GA concentration
of 0.07% the cORF monomer band is diminished, at a GA
concentration higher than 0.2% no cORF-speci¢c bands are
observed any more (not shown). This is most likely because of
massive crosslinking leading to the stabilization of large pro-
tein complexes that are excluded from the gel matrix, indi-
cated by cORF staining at the upper gel border in these sam-
ples. As, in contrast, no bands are observed in extracts from
Raji cells lacking cORF (in the presence and the absence of
GA), all bands observed in Raji-cORF extracts are cORF-
speci¢c. It cannot be ruled out that the high-molecular
cORF species arise due to interactions with heterologous pro-
teins. However, as their laddering matches very well the pre-
dicted molecular weights of cORF mono-, di-, tri- and tetra-
meric forms, they most likely represent cORF oligomers.
3.3. Identi¢cation of the self-association domain
To de¢ne the dimerization domain we used the yeast two-
hybrid system. Deletion mutants of cORF were expressed as
fusion proteins from the vector pJG4-5 and tested against the
full-length wild-type protein (pEG-cORF). While the ¢rst 46
amino acids (aa) and the most C-terminal 18 aa are dispens-
able for self-association, a mutant lacking the C-terminal 30
aa no longer binds to full-length cORF (Fig. 3). These results
con¢ne the dimerization domain to the C-terminal part of the
protein comprising aa 47^87 with the presence of aa 75^87
being absolutely essential for dimer formation. Ongoing stud-
ies using a larger number of partially overlapping deletions
and point mutations will help to acquire an even more de¢ned
picture of the amino acids mediating self-association.
Remarkably, we could identify two domains in cORF to be
substantive for binding to PLZF, one encompassing aa 21^47
and a second one at aa 75^87 [14]. The whole central part of
cORF is thus necessary for PLZF interaction. This stretch is
too large to display a simple linear association epitope. How-
ever, the necessity for this relatively large domain could be
explained if cORF only binds to PLZF as a dimer. In this
suggestive model, the N-terminal part of the interaction do-
main would then mediate direct interaction with PLZF while
the C-terminal part (aa 75^87) confers dimerization. Self-as-
sociation would then be necessary but not su⁄cient for PLZF
interaction, as a mutant unable to bind PLZF can still dimer-
ize.
3.4. Secondary structure prediction of the cORF dimerization
domain
The ¢nding that aa 75^87 in cORF may be part of a di-
merization domain is further substantiated by the fact that aa
73^87 are predicted to form a hydrophobic helical structure
(Fig. 3). Two independent secondary structure prediction
methods were applied (PHD, Columbia University, and Pred-
ator, EMBL, Heidelberg) to the cORF sequence which both
indicate two K-helical regions within the protein. The ¢rst
predicted helical segment encompasses Thr49 to Tyr63
(Trp50^Asn66, Predator) which would result in an amphi-
pathic K-helix. Assuming a helical conformation the side
chains of residues Trp50, Leu53, Leu56, and Leu59 point in
one direction thereby forming a hydrophobic surface, while
the positively charged lysine residues Lys54, Lys55, and Lys62
form the opposing hydrophilic and preferentially solvent-ex-
posed area. This structural model is in agreement with our
previous observation that the leucine-rich region in cORF
forms a NES [3]. The second K-helical secondary structure
is predicted to reach from Pro73 to Val84 (Ser75^Val87, Pred-
ator). This secondary structure element would form a homo-
geneously hydrophobic core fragment with isoleucine, leucine,
valine and methionine residues exposed throughout the entire
helix (Fig. 3). An accumulation of that many hydrophobic
residues is very likely to form the central sca¡old of the folded
protein or ^ since cORF is small-sized ^ to form a seed for
oligomerization. Future studies will reveal whether the pro-
posed correlation of structure and function of the dimeriza-
tion domain can be con¢rmed.
The detection of further characteristics and functions of
cORF, besides HERV-K RNA export, is of particular interest
because of recent evidence that (i) HERV-K expression is
associated with GCTs [13], (ii) cORF has the capacity to
transform cells, and (iii) cORF interacts with PLZF [14].
PLZF is involved in functions such as cell di¡erentiation
and testis development [16,17], suggesting that deregulation
of PLZF, possibly by cORF, might contribute to germ-cell
transformation. We show here the multimerization potential
of cORF. Multimerization is crucial for the activity of Rev
and Rex and thus for the pathogenicity of the respective virus.
Comparably, cORF dimerization may be a prerequisite for
PLZF binding by cORF. With a cORF mutant at hand that
can still dimerize but does not bind to PLZF one could test
for the possibility of a dominant-negative e¡ect of this mutant
on wild-type cORF. If PLZF deregulation by cORF is indeed
implicated in germ-cell tumorigenesis, this could be a ¢rst
approach to inhibit cORF function.
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